Calls
1
u/Due-Papaya-6217
Reddit r/pennystocks
Win Rate
100.0%
return
+180.8%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 14
$3.02
+180.8%
The author argues ImmunityBio is a prime squeeze candidate because free float is only ~89M shares while short interest is 121M, meaning 136% of the float is shorted. Positive ANKTIVA lung cancer data and the chairman's tweet suggest upcoming good news, and the company's presence at the US-Saudi Biotech alliance summit could yield upfront cash. The author frames this as a potential 'baby GME' or DRUG-style squeeze, with the main risk being that the anticipated news or cash does not materialize.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Due-Papaya-6217 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: IBRX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
